DeSanto L W
Laryngoscope. 1984 Oct;94(10):1311-5. doi: 10.1288/00005537-198410000-00010.
This report is a review of 106 Stage III glottic cancers treated surgically from January 1971 through December 1980. For analysis of recurrence and cause of death, the patients were assigned to four subgroups as well as considered as a single group. The subgroups were T3,N0, transglottic, all T3 glottic cancers regardless of prior treatment, and all T3 glottic cancers without prior treatment. Of the entire group, 8% either were not dead or had died of something other than cancer; 91% of patients with T3,N0 cancers without prior treatment either were alive or had died of another cancer. In the other subgroups the survivorship was between 80% and 91% with the exception of those with transglottic cancers. The findings in this study are discussed in light of the current controversies related to the stage of disease, particularly the issue of radical radiation with surgery for salvage for T3 glottic cancer.
本报告回顾了1971年1月至1980年12月期间接受手术治疗的106例III期声门癌患者。为分析复发情况和死亡原因，将患者分为四个亚组，并作为一个整体组进行考量。亚组分别为T3、N0、跨声门型，所有T3期声门癌（无论先前治疗情况如何），以及所有未经先前治疗的T3期声门癌。在整个组中，8%的患者要么未死亡，要么死于癌症以外的其他原因；91%未经先前治疗的T3、N0期癌症患者要么存活，要么死于其他癌症。在其他亚组中，除跨声门型癌症患者外，生存率在80%至91%之间。本研究的结果根据当前与疾病分期相关的争议进行了讨论，特别是T3期声门癌手术挽救性根治放疗的问题。
